BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18623929)

  • 1. Spontaneous interferon production in cultures of a cell line from a human myeloblastic leukemia.
    Deinhardt F; Burnside J
    J Natl Cancer Inst; 1967 Oct; 39(4):681-3. PubMed ID: 18623929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on the interferon production by the leukocytes of healthy and leukaemic subjects.
    Hadházy G; Gergely L; Tóth FD; Szegedi G
    Acta Microbiol Acad Sci Hung; 1967; 14(4):391-7. PubMed ID: 4300286
    [No Abstract]   [Full Text] [Related]  

  • 3. Additional studies of interferon production by human leukemic leukocytes in vitro.
    Lee SH; vanRooyen CE; Ozere RL
    Cancer Res; 1969 Mar; 29(3):645-52. PubMed ID: 4304391
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth regulators in granulopoiesis & status of these factors in myeloid leukemia.
    Rao SG; Pande G; Advani SH; Bhisey AN
    Indian J Exp Biol; 1980 Aug; 18(8):796-9. PubMed ID: 6936384
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostaglandin-like activity in leukemia].
    Bodzenta A; Kiersnowska-Rogowska B; Bielawiec M
    Pol Tyg Lek; 1980 Nov; 35(47):1809-11. PubMed ID: 6937877
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of interferon-like substances by human bone marrow tissues in vitro.
    Northrop RL; Deinhardt F
    J Natl Cancer Inst; 1967 Oct; 39(4):685-9. PubMed ID: 18623930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Imbalance of hormones regulating the phosphocalcium metabolism in myeloid leukemia].
    Rico Lenza H; Díaz Mediavilla J; Hernández Díaz ER; Jara Orellana N; Bordiu Obanza E; Charro Salgado A; Espinós Pérez D
    Med Clin (Barc); 1984 Jan; 82(2):54-6. PubMed ID: 6584702
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucocorticoid-induced tumor necrosis factor receptor-related protein ligand subverts immunosurveillance of acute myeloid leukemia in humans.
    Baessler T; Krusch M; Schmiedel BJ; Kloss M; Baltz KM; Wacker A; Schmetzer HM; Salih HR
    Cancer Res; 2009 Feb; 69(3):1037-45. PubMed ID: 19155305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of leukocytes in patients with chronic myeloleukemia].
    Morozova VT; Shevchenko NG; Vereshchagina GV; Trusova NF; Bektermirov TA
    Lab Delo; 1971; 8():462-6. PubMed ID: 4114037
    [No Abstract]   [Full Text] [Related]  

  • 10. Imbalance in nucleotide pools of myeloid leukemia cells and HL-60 cells: correlation with cell cycle phase, cell proliferation and differentiation.
    de Korte D; Haverkort WA; de Boer M; Roos D; van Gennip AH
    Adv Exp Med Biol; 1986; 195 Pt B():437-41. PubMed ID: 3464163
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of a new myeloid leukemia cell line with normal cytogenetics (CG-SH).
    Munker R; Nordberg ML; Veillon D; Williams BJ; Roggero A; Kern W; Dicker F; Haferlach T
    Leuk Res; 2009 Oct; 33(10):1405-8. PubMed ID: 19414191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of extramedullary myeloid tumor in patients with continuous remission of acute myeloblastic leukemia.
    Slavcheva V; Lukanov T; Tzvetkov N
    J BUON; 2008; 13(4):589-92. PubMed ID: 19145688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction, production, and concentration of interferon produced by a myeloblast culture.
    Familletti PC; Costello L; Rose CA; Pestka S
    Methods Enzymol; 1981; 78(Pt A):83-6. PubMed ID: 6173651
    [No Abstract]   [Full Text] [Related]  

  • 14. The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells.
    Smits EL; Cools N; Lion E; Van Camp K; Ponsaerts P; Berneman ZN; Van Tendeloo VF
    Cancer Immunol Immunother; 2010 Jan; 59(1):35-46. PubMed ID: 19449004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased interferon production of leukocytes in vitro in chronic myelocytic leukemia].
    Hadhazy G; Gergely L; Toth F; Szegedi G
    Klin Wochenschr; 1968 May; 46(10):560. PubMed ID: 5247042
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of 17DMAG, a geldanamycin derivative, in murine acute myeloid leukemia.
    Panarsky R; Reichert F; Ben-Ishay Z
    Acta Haematol; 2009; 121(1):32-6. PubMed ID: 19332984
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction and production of human interferon with human leukemic cells.
    Hershberg RD; Gusciora EG; Familletti PC; Rubinstein S; Rose CA; Pestka S
    Methods Enzymol; 1981; 78(Pt A):45-8. PubMed ID: 6173628
    [No Abstract]   [Full Text] [Related]  

  • 18. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.
    Pigazzi M; Manara E; Baron E; Basso G
    Cancer Res; 2009 Mar; 69(6):2471-8. PubMed ID: 19258499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells.
    Lion E; Smits EL; Berneman ZN; Van Tendeloo VF
    Leuk Res; 2009 Apr; 33(4):539-46. PubMed ID: 18845337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro biology of human myeloid leukemia.
    Mayani H; Flores-Figueroa E; Chávez-González A
    Leuk Res; 2009 May; 33(5):624-37. PubMed ID: 19108888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.